ZELTIQ to Present at J.P. Morgan Healthcare Conference
January 06 2014 - 8:30AM
ZELTIQ® (Nasdaq:ZLTQ), a medical technology company focused on
developing and commercializing products utilizing its proprietary
controlled-cooling technology platform, today announced that Mark
Foley, President and Chief Executive Officer, is scheduled to
present at the 32nd Annual J.P. Morgan Healthcare Conference at the
Westin St. Francis Hotel in San Francisco.
Event: J.P. Morgan Healthcare
Conference
Date: January 15, 2014
Time: 3:00 p.m. PT
An audio webcast of the Company's presentation will be available
by visiting the investor relations section of ZELTIQ's web site at
www.coolsculpting.com. A replay of the presentation will be
available for 90 days.
About ZELTIQ® Aesthetics, Inc.
ZELTIQ is a medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ's first
commercial product, the CoolSculpting System, is designed to
selectively reduce stubborn fat that may not respond to diet or
exercise. CoolSculpting is based on the scientific principle
that fat cells are more sensitive to cold than the overlying skin
and surrounding tissues. It utilizes patented technology of
precisely controlled cooling to reduce the temperature of fat cells
in the treated area, which is intended to cause fat cell
elimination through a natural biological process known as
apoptosis. ZELTIQ developed CoolSculpting to safely,
noticeably, and measurably reduce the fat layer.
CONTACT: Investor Relations:
Patrick F. Williams
ZELTIQ, Senior Vice President and CFO
925-474-2500
Nick Laudico / Rada Milenovici
The Ruth Group
646-536-7030 / 646-536-7011
nlaudico@theruthgroup.com
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024